Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Jun 3;16(6):e61599.
doi: 10.7759/cureus.61599. eCollection 2024 Jun.

Exploring Splice-Site Mutations in LAMA2-Related Muscular Dystrophies: A Comprehensive Analysis of Genotypic and Phenotypic Patterns

Affiliations
Case Reports

Exploring Splice-Site Mutations in LAMA2-Related Muscular Dystrophies: A Comprehensive Analysis of Genotypic and Phenotypic Patterns

Samira Nmer et al. Cureus. .

Abstract

LAMA2-related muscular dystrophies (LAMA2-RDs) constitute the most prevalent subtype of congenital muscular dystrophies (CMDs). The clinical spectrum of LAMA2-RDs exhibits considerable diversity, particularly in motor development and disease progression. Phenotypic variability ranges from severe, early-onset presentation, known as merosin-deficient CMD type 1A, to milder, late-onset presentations, including limb-girdle muscular dystrophy-like phenotype. In this study, whole exome sequencing (WES) was applied to a family with a single proband affected by severe muscular dystrophy. The identified causative mutation was a biallelic splice-site mutation in intron 58 of the LAMA2 gene, leading to a premature termination codon in the critical G domain of laminin-α2 and resulting in a severe phenotype. Additionally, we summarized previously reported splice-site mutations to investigate the clinical and transcription consequences of these mutations. Our findings conclude that splice-site mutations predominantly lead to severe MDC1A, whether in a homozygous or heterozygous state, often associated with another loss-of-function mutation. Besides, splice-site mutations with available analysis of their transcriptional consequences were found to be responsible for exon skipping in most cases and the loss of the reading frame. These findings revealed the importance of WES in identifying disease-causing mutations, particularly in highly diversified pathologies like LAMA2-RDs. The results also underscore the importance of transcriptional analysis in determining the impact of splice-site mutations and the phenotype of LAMA2-RDs on patients.

Keywords: lama2-related muscular dystrophies; laminin-α2; lgmd-like phenotype; mdc1a; splice-site mutations; whole exome sequencing.

PubMed Disclaimer

Conflict of interest statement

Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. Results of the MRI scan of the case
From A to F, the images show changes in the frontoparietal and periventricular white matter of the patient
Figure 2
Figure 2. Sanger sequencing results of the case
The electropherogram shows a single green peak at position 8244+1 (designated by the arrow) corresponding to a homozygous substitution of G with A.
Figure 3
Figure 3. Sanger sequencing results of the parents of the case
The electropherogram shows two peaks at position 8244+1 (designated by the arrow) corresponding to the nucleotides G and A, which demonstrates a heterozygous substitution of G with A.

Similar articles

References

    1. Congenital muscular dystrophies and myopathies: an overview and update. Schorling DC, Kirschner J, Bönnemann CG. Neuropediatrics. 2017;48:247–261. - PubMed
    1. Diagnostic approach to the congenital muscular dystrophies. Bönnemann CG, Wang CH, Quijano-Roy S, et al. Neuromuscul Disord. 2014;24:289–311. - PMC - PubMed
    1. The congenital muscular dystrophies in 2004: a century of exciting progress. Muntoni F, Voit T. Neuromuscul Disord. 2004;14:635–649. - PubMed
    1. Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies. Gawlik KI, Durbeej M. Skelet Muscle. 2011;1:9. - PMC - PubMed
    1. LAMA2-related dystrophies: clinical phenotypes, disease biomarkers, and clinical trial readiness. Sarkozy A, Foley AR, Zambon AA, Bönnemann CG, Muntoni F. Front Mol Neurosci. 2020;13:123. - PMC - PubMed

Publication types

LinkOut - more resources